Evidence map›Paper›PMID 18709391›Full record

ArticlePediatric nephrology (Berlin, Germany)2009

Genetic forms of nephrotic syndrome: a single-center experience in Brussels.

Khalid Ismaili, Audrey Pawtowski, Olivia Boyer, Karl Martin Wissing, Françoise Janssen, Michelle Hall

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Podocin oligomers regulate the ordering of nephrin chains, providing the molecular basis ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Congenital nephrotic syndrome.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Review
  4. Article
  5. Article
  6. A no-nonsense approach to hereditary kidney disease.Pediatric nephrology (Berlin, Germany) · 2020
    Review
  7. Article
  8. The Role of p.Ser1105Ser (inMedicina (Kaunas, Lithuania) · 2019
    Article
  9. Review
  10. Review
  11. Three Novel Mutations in theCase reports in genetics · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome.Journal of the American Society of Nephrology : JASN · 2010
    Article
4 · The record

Corrections and comments

  • Erratum issued
    Pawtowski, Audrey [added]; Boyer, Olivia [added]
5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Khalid IsmailiDepartment of Pediatric Nephrology, Hôpital Universitaire des Enfants - Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium. khalid.ismaili@huderf.be
Audrey Pawtowski
Olivia Boyer
Karl Martin Wissing
Françoise Janssen
Michelle Hall
Queen Fabiola Children's University Hospital · BEErasmus Hospital · BEUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to present our experience in treating children with genetic forms of nephrotic syndrome and diagnosing these diseases. We retrospectively reviewed the clinical data, mutational analyses, histopathological features, treatment modalities, and outcome of 26 consecutive children (20 families) suffering from congenital and/or steroid-resistant nephrotic syndrome who were assessed by genetic analysis. Ten out of 26 children (38%) had congenital nephrotic syndrome, 4/26 (15%) had infantile nephrotic syndrome, 10/26 (38%) had late-onset nephrotic syndrome, and 2/26 (9%) had asymptomatic proteinuria. We detected a mutation in 21/26 (81%) patients and in 15/20 (75%) families. NPHS1 mutation analyses were positive in 4/20 (20%), NPHS2 mutations in 4/20 (20%), WT1 mutations in 4/20 (20%), and PLCE1 mutations in 3/20 (15%) families. NPHS1 and PLCE1 mutations were solely found in patients with the earliest onset. The majority of patients, especially those with early onset of nephrotic syndrome, had serious adverse events related to the nephrotic status, and 19/26 (73%) reached end-stage renal failure at a median age of 27 months. Genetic forms of nephrotic syndrome comprise a heterogeneous group of genetic mutations. The progression toward end-stage renal failure is the rule but is highly variable between patients.

Indexed as

AdolescentAge of OnsetBelgiumChildChild, PreschoolDenys-Drash SyndromeFemaleFrasier SyndromeHumansInfantInfant, NewbornIntracellular Signaling Peptides and ProteinsKidney NeoplasmsMaleMembrane ProteinsNephrotic SyndromeIntracellular Signaling Peptides and ProteinsMembrane ProteinsnephrinNPHS2 proteinPhosphoinositide Phospholipase Cphospholipase C epsilonWT1 Proteins

Identifiers

PMID18709391
OpenAlexW2020289798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.